Abortion foes worried before his election that President Donald Trump had moved on, now that Roe v. Wade is overturned and abortion policy, as he said on the campaign trail, “has been returned to the states.” Their concerns mounted after Trump named Robert F. Kennedy Jr., a longtime supporter of abortion rights, to lead the…
The average Affordable Care Act (ACA) Marketplace deductible experienced the steepest increase in history—growing by 37% or over $1,000, from $2,759 in 2025 to $3,786 in 2026 as enhanced premium tax credits expired, according to a new KFF analysis. After the enhanced tax credits ended, many Marketplace shoppers shifted toward lower-premium, higher-deductible plans.
The federal government scaled back its recommended childhood vaccines, sidelining six that have safeguarded millions from serious diseases, long-term disability, and death. Just three of those that the Centers for Disease Control and Prevention says it will no longer routinely recommend — against hepatitis A, hepatitis B, and rotavirus — have prevented nearly 2 million hospitalizations and 90,000 deaths in the…
This policy watch discusses a recent policy change by the Department of Health and Human Services that bars several groups of immigrants from accessing an updated list of “federal public benefits”.
By MATTHEW HOLT Strap in for the tale of why your hero is spending most of his life down YouTube rabbit holes of cardiology videos while blundering his way around many many medical centers and exposing many problems with American health care even before he gets close to the operating table. Yes it’s Matthew Holt’s…
Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 2023. The post Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023 appeared first on MedCity News.
BridgeBio Pharma’s approval of Beyonttra comes three months after the drug landed FDA approval for cardiomyopathy caused by transthyretin amyloidosis. Our recap of recent regulatory news also spans approvals in cancer, immunology, vaccines, and more. The post On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval appeared first on MedCity…
Deploying AI-driven segmentation at an enterprise level goes beyond operational efficiency. It signals a commitment to pioneering the next era of precision healthcare. The post Reimbursing Your Digital Twin: A New Era In Patient-Specific Surgery appeared first on MedCity News.
Accuracy, completeness, and efficiency all matter when benchmarking a successful AI platform. But there’s another metric that’s often overlooked: the minutes of eye contact returned to the exam room. The post The Multimodal Explosion: Why 2026 Breaks the AI Paradigm appeared first on MedCity News.
At NAACOS meeting, LTC ACO’s Kristen Krzyżewski explains the savings opportunities available when taking a value-based care approach